Legal Representation
Attorney
Norm J. Rich and Katherine P. Califa
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 15, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 15, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 7, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 6, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 6, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 4, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 4, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 4, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 2, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 2, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 8, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 6, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 6, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 6, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 27, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 27, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 27, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 25, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 23, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 23, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 9, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 14, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 14, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 22, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 30, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 21, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 21, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 21, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 23, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 14, 2016 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 13, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 9, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 036
Providing grants for medical education and for sponsorship of events related to patient advocacy and medical conferences
Additional Information
Design Mark
The mark consists of an abstract drawing of human lungs with a heart in the center appearing in white on a gray circular background; the gray circle has a thin red border on the left and a thin blue border on the right; a blue line extends horizontally from the upper left of the circle and a red line extends horizontally from the lower right of the circle; the wording "UNITED THERAPEUTICS CORPORATION" appears in black below the blue line and the wording "LUNG", in blue, and "BIOTECHNOLOGY", in green, appears above the red line.
Color Claim
The color(s) black, white, grey, red, blue, and green is/are claimed as a feature of the mark.
Classification
International Classes
036
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS CORPORATION" AND "LUNG BIOTECHNOLOGY"